Bobby Gaspar serves as Executive at Orchard Therapeutics plc, where they oversee executive responsibilities. Since joining the company, Bobby Gaspar has executed 6 insider transactions totaling $75.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 24, 2024 involved selling 366,158 shares valued at $0.
Bobby Gaspar currently holds 366,158 shares of Orchard Therapeutics plc (ORTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bobby Gaspar has been a net seller of ORTX stock. They have purchased $11.1K and sold $64.0K worth of shares.
Bobby Gaspar's most recent insider trade was on Jan 24, 2024, when they sold 366,158 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.74 |
| Discretionary |
| Jan 11, 2021 | ORTX | $22.9K | Payment | 3,411 | $6.72 | Discretionary |
| Jan 8, 2021 | ORTX | $0 | Award | 6,250 | $N/A | Discretionary |
| Mar 2, 2020 | ORTX | $0 | Option Exercise | 4,921 | $N/A | Discretionary |
| Mar 2, 2020 | ORTX | $64.0K | Sale | 4,921 | $13.00 | Discretionary |